| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/16/2008 | US20080255066 Two or more antisense oligonucleotides complementary to a thymidylate synthase mRNA; enhanced cancer tissue penetration or neoplastic cellular uptake of antisense agent molecules |
| 10/16/2008 | US20080255065 In combination with one or more anti-cancer therapeutics inhibits neoplastic cell proliferation; siRNA molecule decreased gemcitabine chemoresistance of pancreatic adenocarcinoma cells in vivo, demonstrating a synergistic effect when administered in combination with gemcitabine |
| 10/16/2008 | US20080255064 Biological assay; experimental reporter expression vector has cholecystokinin promoter upregulating agent operably linked to experimental Renilla luciferase reporter gene; separately detectable; co-transform experimental vector and control vector in pancreatic islet host cells; increase plasma insulin |
| 10/16/2008 | US20080255063 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF |
| 10/16/2008 | US20080255062 Axon regeneration from adult sensory neurons |
| 10/16/2008 | US20080255061 To enhance the sensitivity of drug-resistant tumor cells to chemotherapeutic drugs; treating P-gp or Bcl-2 over-expression, or glyoxylase I over-activity; phthalide derivatives such as dimers and spiro-ring derivatives, obtained as plant extracts from ligusticus wallichii franchet or angelica |
| 10/16/2008 | US20080255060 Semi-synthetic antimicrobial;therapy or prophylaxis of systemic or topical infections; 4''-O-(3-{4-[3-(3-Ethoxycarbonyl-1-ethyl-4-oxo-1,4-dihydro-quinolin-6-yl)-prop-2-ynyl]-piperazin-1-yl}-propionyl)-azithromycin; excipient, diluent, carrier |
| 10/16/2008 | US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 10/16/2008 | US20080255058 Composition for Oral Cavity |
| 10/16/2008 | US20080255057 Prodrug substituted benzoxazoles as estrogenic agents |
| 10/16/2008 | US20080255056 Salts of isophosphoramide mustard and analogs thereof |
| 10/16/2008 | US20080255050 Administering 2-aminopurine or a pharmaceutically salt thereof; optionally also administering an additional hypolipidemic agent; 2-AP and nonphosphorylatable eIF-2 alpha mutant inhibit eIF-2 alpha phosphorylation, inhibit foam cell formation and atherosclerosis development |
| 10/16/2008 | US20080255042 CaSR Antagonist |
| 10/16/2008 | US20080255036 Substituted thiophenes |
| 10/16/2008 | US20080255034 Apparatus comprises an ablator that is configured to generate a microporation in area of skin of patient, and comprising a drug which effects biological regulation of at least one of oocyte containing follicle, stimulation of follicle growth, induction of ovulation, promotion of gestational status |
| 10/16/2008 | US20080255031 Method for enhancing insulin secretion |
| 10/16/2008 | US20080255030 Compositions and methods for the modulation of jnk proteins |
| 10/16/2008 | US20080255029 Neuroendocrine Tumor Treatment |
| 10/16/2008 | US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE |
| 10/16/2008 | US20080254487 Immunoglobulin which intereferes with interaction of heparan sulfate proteoglycans and cell growth factors; antitumor agents; cell adhesion modulator |
| 10/16/2008 | US20080254157 Herbal composition for inflammatory disorders |
| 10/16/2008 | US20080254155 Modulating gene expressions of key enzymes associated with cholesterol metabolism in vivo; natural source; anticholesterol agents |
| 10/16/2008 | US20080254153 Water Dispersible Composition and Method for Preparing Same |
| 10/16/2008 | US20080254152 Inhibiting glucocorticoid-induced chronic stress in a dermal cell or a cell involved in skin inflammatory responses |
| 10/16/2008 | US20080254150 Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations |
| 10/16/2008 | US20080254149 Solvent extraction of plant material from which oils have been distilled previously; phenolic compounds, flavones, isoflavones, glycosides, anthocyanins, proanthocyanidins, procyanidins, catechins, terpenes, lignins, tannins, glucosinilates, aliphatic and cyclic organic acids |
| 10/16/2008 | US20080254142 Compositions and methods for nutrition supplementation |
| 10/16/2008 | US20080254140 treating vision defects of macular degeneration, atrophy of the pigmented epithelium of the retina and photoreceptors in an eye; reducing the formation of drusen in an eye of a human; isotretinoin |
| 10/16/2008 | US20080254136 controlling protozoa by administering shikonin or shikonin derivatives; treating leishmaniasis; plant extracts being derived from Lithospermi Radix |
| 10/16/2008 | US20080254135 Resveratrol-containing compositions for general health and vitality |
| 10/16/2008 | US20080254131 core comprising a water insoluble polymer and acetylcholinesterase inhibitor, a release rate controlling coatings is surrounding the core including a release retarding excipient; administered less frequently, provide more stable blood levels; improve pharmacokinetic; dementia, mania, nicotine dependence |
| 10/16/2008 | US20080254130 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction |
| 10/16/2008 | US20080254128 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| 10/16/2008 | US20080254127 Inhalation particles incorporating a combination of two or more active ingredients |
| 10/16/2008 | US20080254123 Morphine polymer release system |
| 10/16/2008 | US20080254121 sustained release dosage form has first-layer, second-layer and inner-core containing different amounts of melatonin; controlled release for sleep; improve sleep quality, treating insomnia |
| 10/16/2008 | US20080254119 nutritional supplement tablet comprises an oily liquid Vitamin E finely dispersed in an oil insoluble material; providing lubrication; free of magnesium stearate, free of undesirable problem; increase bonding, compressibility and tablet hardness |
| 10/16/2008 | US20080254118 Process for preparing pramipexole dihydrochloride tablets |
| 10/16/2008 | US20080254117 Process for preparing pramipexole dihydrochloride tablets |
| 10/16/2008 | US20080254116 Delta and Epsilon Crystal Forms of Imatinib Mesylate |
| 10/16/2008 | US20080254114 Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles |
| 10/16/2008 | US20080254113 Microemulsion Formulations Comprising Particular Substance P Antagonists |
| 10/16/2008 | US20080254110 Composition For Enhancing Immunity and Reducing Inflammation Related to Infections |
| 10/16/2008 | US20080254109 Delivering therapeutic nucleic acid into adjacent normal heart tissue; inducing angiogenesis and collateral blood vessel formation |
| 10/16/2008 | US20080254107 Transdermal absorbtion and/or adsorbtion removal of inflammatory body fluids; such as dextrin, crushed tourmaline, chitosan and sorbic acid; skin patches |
| 10/16/2008 | US20080254106 Using antidepressant drug 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino[3,2,1-jk]carbazole (pirlindole) in combination with other active agents; topical delivery |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254101 Pilocarpine compositions and methods of use thereof |
| 10/16/2008 | US20080254100 Producing blunted postprandial glycemic response; using nutritional meal replacements that are rapidly metabolized and absorbed in small intestine; reducing body weight |
| 10/16/2008 | US20080254099 Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease |
| 10/16/2008 | US20080254098 Neural tube birth defect reduction with folic acid delivery in catamenial hygiene products |
| 10/16/2008 | US20080254097 Active detergent and biodegradable carrier; contacting adjacent tissue and promoting dissolution of retropubic fat; suppressing stress induced leakage |
| 10/16/2008 | US20080254096 Using polyvinyl alcohol free biodegradable polymer matrix; reducing side effects, invasive procedures and high transient concentrations; glaucoma, proliferative vitreoretinopathy |
| 10/16/2008 | US20080254095 Delivery device and method for forming the same |
| 10/16/2008 | US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle |
| 10/16/2008 | US20080254091 Multi-Layered Antiadhesion Barrier |
| 10/16/2008 | US20080254089 Prefilled DAIKYO CZ plastic syringe heat sterilisable; unit dose 2-(imidazol-1yl)-1-hydroxyethane-1 pre-concentrate solution; buffering, isotonising agent; endotoxin, pyrogen-free after autoclaving |
| 10/16/2008 | US20080254085 Degradable Polymers Incorporating Gamma-Butyrolactone |
| 10/16/2008 | US20080254078 Simple, binary system of hydrophilic nanoparticles using cationic chitosan and anionic polysaccharides having carboxymethyl groups and/or sulfate groups; adjustable zeta potential of aqueous colloidal suspensions; binding biological groups covalently; drug delivery; foods; cosmetics; biocompatability |
| 10/16/2008 | US20080254077 Core/shell particles based on silicone compounds |
| 10/16/2008 | US20080254073 Transdermal Patch Comprising Paroxetine |
| 10/16/2008 | US20080254072 Method For Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens |
| 10/16/2008 | US20080254059 Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby |
| 10/16/2008 | US20080254053 Treating systemic inflammation via reducing c-reactive protein levels in the body |
| 10/16/2008 | US20080254042 Using prolactin-releasing peptide (PrRP) to identify modulators for prevention and treatment of nervous system, heart, hepatic and anxiety disorders |
| 10/16/2008 | US20080254040 Antagonists of receptors of enothelial growth factor, platelet-derived growth factor, fibroblast growth factor, epidermal growth factors, HER2, IGF1R, HGFR or c-Kit, which is further an antagonist of a src tyrosine kinase family member, and chemotherapeutic agent; co-treatment with radiation therapy |
| 10/16/2008 | US20080254036 Contains [2-({4-[(dimethylamino)iminomethyl]phenyl}carbonylamino)-5-methoxyphenyl]-N-(5-chloro(2-pyridyl))carboxamide (betrixaban) and antiplatelet agent for treatment of thrombosis; kits |
| 10/16/2008 | US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders |
| 10/16/2008 | US20080254033 Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases |
| 10/16/2008 | US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders |
| 10/16/2008 | US20080254029 Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis |
| 10/16/2008 | US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders |
| 10/16/2008 | US20080254023 Using erythropoietin-producing hepatocelluar kinase receptor specific interfering RNA for treatment and prevention of brain, nervous system and spinal cord disorders |
| 10/16/2008 | US20080254022 Method of Treating Airway Diseases With Beta-Adrenergic Inverse Agonists |
| 10/16/2008 | US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue |
| 10/16/2008 | US20080254017 Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids |
| 10/16/2008 | US20080254016 Composition For Increasing Anti-Oxidation Activity In Blood |
| 10/16/2008 | US20080254015 For application to wounds; bacteriostats |
| 10/16/2008 | US20080254010 Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract |
| 10/16/2008 | US20080254009 Using probiotic culture comprising metronidazole, bacitracin or vancomycin as therapeutic in treatment of diarrhea and inflammatory bowel diseases |
| 10/16/2008 | US20080253998 Treatment of cancer using tlr3 agonists |
| 10/16/2008 | US20080253995 For treatment of Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and rhinovirus infection |
| 10/16/2008 | US20080253989 Neuron Regeneration |
| 10/16/2008 | US20080253988 Pyrrolo [1,2-D] [1,2-4] Triazine as Inhibitors of C-Jun N Terminal Kinases (Jnk) and P-38 Kinases |
| 10/16/2008 | US20080253987 Biomaterial from precursors pentaerythritol poly(ethylene glycol)ether tetra-sulfhydryl and an ethylene oxide-propylene oxide star polymer having ethylene diamine as the nucleus and acrylate end groups; containing biological fluids or gases; nonswelling, high mechanical strength, biocompatability |
| 10/16/2008 | US20080253986 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers |
| 10/16/2008 | US20080253985 Sequentially or concurrently administering three active ingredients comprising an MTP inhibitor, a cholesterol absorption inhibitor, at least one of a HGM-CoA reductase inhibitor, a bile acid sequestrant, a fibric acid derivative, niacin, and a squalene sythetase inhibitor |
| 10/16/2008 | US20080253984 Topically applying an inexpensive, non-prescription, safe, polymerizable, hydrophobic, elastomeric solution of a polyether diamine, a secondary aromatic diamine, a polyisocyanate and a polyol to form a urea-linked polyetherurethane copolymer upon drying |
| 10/16/2008 | US20080253982 Ascorbic acid derivatives and skin-whitening cosmetics |
| 10/16/2008 | US20080253974 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benz(enesulfon)amide and a second cooling agent, such as menthol or a derivative; similar cooling intensity to N-ethyl p-menthanecarboxamide (WS-3); ingestible or topical |
| 10/16/2008 | US20080253971 Particles for inhalation having sustained release properties |
| 10/16/2008 | US20080253969 Multi-functional polyglutamate drug carriers |
| 10/16/2008 | US20080253967 Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques |
| 10/16/2008 | US20080253966 Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer |
| 10/16/2008 | US20080253965 Small-Molecule Hsp90 Inhibitors |
| 10/16/2008 | US20080253961 Drug delivery; biocompatable polyesters; biodegradable glycolic acid-lactic acid nanoshell (PLGA); controlled release |
| 10/16/2008 | US20080253960 Cell surface receptor ligand is covalently bonded to apoprotein; photodynamic therapy; antiglaucoma agents |
| 10/16/2008 | DE202008010089U1 Exakt teilbare Filmtablette Exactly divisible tablet |
| 10/16/2008 | DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments |
| 10/16/2008 | DE102007017290A1 Use of viologen dendrimer having 4, 4'-bipyridinium structure for e.g. transporting oligonucleotides, ribonucleic acid, and single and double stranded DNA in eukaryotic cells; and therapeutic methods in humans and animals |